Literature DB >> 8683299

[Methyl-carbon-11] thymidine for in vivo measurement of cell proliferation.

P Goethals1, N Lameire, M van Eijkeren, D Kesteloot, H Thierens, R Dams.   

Abstract

UNLABELLED: [Methyl-11C]thymidine and PET provide an in vivo, noninvasive, quantitative approach for studying nucleoside uptake in cells on condition that the fraction of metabolites in the total accumulated activity is known.
METHODS: Using an animal model (Wistar rats), two independent approaches were followed. In the first approach, total accumulated activity in rapidly dividing tissue after intravenous injection of [methyl-11C]thymidine, respectively, [methyl-11C]thymine (first metabolite), was compared. In the second approach, the liver was surgically isolated to avoid thymidine catabolism.
RESULTS: After injection of [methyl-11C]thymidine, tissue activity consists of both labeled thymidine and metabolites, while after injection of [methyl-11C]thymine, it consists only of metabolites. The fraction of metabolites ranged from 9% to 44%. Comparing the specific activity with and without liver function yielded similar results. The calculated amount of metabolites was about 10%.
CONCLUSION: In spite of the intense in vivo catabolism, major activity in rapidly dividing tissue consists of [methyl-11C]thymidine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8683299

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

Review 1.  Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.

Authors:  D A Mankoff; F Dehdashti; A F Shields
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer.

Authors:  Haihao Sun; Andrew Sloan; Thomas J Mangner; Ulka Vaishampayan; Otto Muzik; Jerry M Collins; Kirk Douglas; Anthony F Shields
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-01       Impact factor: 9.236

3.  PET Radiotracers for Imaging the Proliferative Status of Solid Tumors.

Authors:  Robert H Mach; Farrokh Dehdashti; Kenneth T Wheeler
Journal:  PET Clin       Date:  2009-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.